Jiang Ren-Di, Luo Yun-Zhe, Lin Hao-Feng, Zheng Xiao-Shuang, Zeng Wen-Tao, Liu Mei-Qin, Deng Hao-Hao, Wang Qi, Lai Ya-Na, Chen Ying, Guo Zi-Shuo, Zeng Ya, Gong Qian-Chun, Qiu Chen, Dong Mei, Wang Xi, Wang Zi-Yi, Ji Li-Na, Hou Pan-Pan, Li Qian, Shen Xu-Rui, Li Bei, Gao Yun, Zhang Ai-Hua, Jiang Ting-Ting, Shi Ai-Min, Zhou Peng, Lin Xin-Hua, Deng Zi-Qing, Li Jian-Min, Shi Zheng-Li
State Key Laboratory of Genetic Engineering, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.
BGI Research, Beijing, China.
iScience. 2025 Jan 17;28(2):111837. doi: 10.1016/j.isci.2025.111837. eCollection 2025 Feb 21.
Comorbidities, such as obesity, increase the risk of severe COVID-19. However, the mechanisms underlying severe illnesses in individuals with obesity are poorly understood. Here, we used gene-edited leptin knock out ( ) obese hamsters to establish a severe infection model. This model exhibits robust viral replication, severe lung lesions, pronounced clinical symptoms, and fatal infection, mirroring severe COVID-19 in patients with obesity. Using single-cell transcriptomics on lung tissues pre- and post-infection, we found that monocyte-derived alveolar macrophages (MD-AM) play a key role in lung hyper-inflammation, including two unique MD-AM cell fate branches specific to hamsters. Notably, reduced Trem2-dependent efferocytosis pathways in hamsters indicated weakened inflammation resolution, consistent with the scRNA-seq data from patients with obesity. In summary, our study highlights the obesity-associated mechanisms underlying severe SARS-CoV-2 infections and establishes a reliable preclinical animal model for developing obesity-specific therapeutics for critical COVID-19.
肥胖等合并症会增加患重症COVID-19的风险。然而,肥胖个体罹患重症疾病的潜在机制尚不清楚。在此,我们使用基因编辑的瘦素敲除肥胖仓鼠建立了一个严重感染模型。该模型表现出强劲的病毒复制、严重的肺部病变、明显的临床症状和致命感染,与肥胖患者的重症COVID-19情况相似。通过对感染前后肺组织进行单细胞转录组学分析,我们发现单核细胞衍生的肺泡巨噬细胞(MD-AM)在肺部过度炎症中起关键作用,包括两个特定于肥胖仓鼠的独特MD-AM细胞命运分支。值得注意的是,肥胖仓鼠中依赖Trem2的胞葬作用途径减少表明炎症消退减弱,这与肥胖患者的单细胞RNA测序数据一致。总之,我们的研究突出了肥胖相关的重症SARS-CoV-2感染潜在机制,并建立了一个可靠的临床前动物模型,用于开发针对重症COVID-19的肥胖特异性治疗方法。